# Achieve Life Sciences, Inc.: Form 8-K, filed Feb 29, 2024

- Company: [Achieve Life Sciences, Inc.](/companies/achv.md) (CIK 949858)
- Form: 8-K
- Filed: 2024-02-29
- Accepted by EDGAR: Feb 29, 2024, 21:41 ET
- Period: 2024-02-28
- Accession: 0000950170-24-023189
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/949858/000095017024023189/achv-20240228.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/949858/000095017024023189/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.02: Results of operations
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/949858/000095017024023189/achv-20240228.htm

Filed Feb 29, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-023189. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.